Ribosomal Ribonucleic Acid Hybridization for Organism Identification
Abstract
The present disclosure relates to method of distinguishing between two or more species of one or more organisms in a sample, by contacting a biological sample comprising ribosomal ribonucleic acid (rRNA) with a set of antisense probes, wherein the set of probes contains at least one detectable probe that is specific for a target rRNA sequence of each species to be tested, and wherein the individual probes specific for each species comprises less than about 85% sequence identity; and, detecting hybridization between one or more of the probes and the rRNA, thereby distinguishing between two or more species in a sample.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of distinguishing between two or more species of one or more organisms in a sample, comprising:
contacting a sample comprising ribosomal ribonucleic acid (rRNA) with a set of antisense probes, wherein the set of probes contains at least one detectable probe that is specific for a target rRNA sequence of each species to be tested, and wherein the individual probes specific for each species have about 85% or less sequence identity to the probes for the other species; and, detecting hybridization between one or more of the probes and the rRNA, thereby distinguishing between two or more species in a sample.
2 . The method of claim 1 , further comprising determining the at least one detectable probe that is specific for a target rRNA sequence of each species, wherein the determination comprises:
determining shared rRNA sequences between members of each of the two or more species; determining divergent rRNA sequences between each of the two or more species, wherein the divergent rRNA sequences share 85% or less sequence identity, to identify a target RNA sequence for each species; and designing a probe for the target rRNA sequence of each species that specifically binds to the shared rRNA sequences between members of a given species, wherein the individual probes for are each species are about 85% or less identical.
3 . The method of claim 1 , wherein the one or more organisms comprise one or more microorganism.
4 . The method of claim 2 , wherein the one or more microorganism is selected from the group consisting of bacteria, yeast, and fungi or a combination thereof.
5 . The method of claim 3 or 4 , wherein the one or more microorganism is a human pathogen.
6 . The method of any one of claims 3 - 5 , wherein the one or more microorganism comprises bacteria.
7 . The method of claim 4 - 5 , wherein the one or more microorganism comprises one or more of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter baumannii, Candida albicans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Proteus mirabilis, Streptococcus agalactiae , or Stenotrophomonas maltophilia.
8 . The method of any one of claims 1 - 7 , wherein the target rRNA sequence of each species to be tested comprise at least 2 of the nucleic acid sequences set forth as SEQ ID NO: 107-159, and wherein each species specific probe in set of antisense probes specifically binds to the nucleic acid sequences set forth as SEQ ID NOs: 107-159.
9 . The method of any one of claims 1 - 8 , wherein the set of antisense probes comprises one or more probes to Escherichia coli , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 59, SEQ ID NO: 60, or SEQ ID NO: 64, SEQ ID NO: 65, SEQ ID NO: 66, SEQ ID NO: 67, SEQ ID NO: 68, SEQ ID NO: 69, SEQ ID NO: 70, or SEQ ID NO: 71.
10 . The method of any one of claims 1 - 9 , wherein the set of antisense probes comprises one or more probes to Klebsiella pneumoniae , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 72, SEQ ID NO: 73, SEQ ID NO: 74, SEQ ID NO: 75, SEQ ID NO: 76, or SEQ ID NO: 77, or SEQ ID NO: 78.
11 . The method of any one of claims 1 - 10 , wherein the set of antisense probes comprises one or more probes to Pseudomonas aeruginosa , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, or SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 79, SEQ ID NO: 81, SEQ ID NO: 82, SEQ ID NO: 83, SEQ ID NO: 84, SEQ ID NO: 85, or SEQ ID NO: 86, or SEQ ID NO: 87.
12 . The method of any one of claims 1 - 11 , wherein the set of antisense probes comprises one or more probes to Staphylococcus aureus , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 40, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45, SEQ ID NO: 46, SEQ ID NO: 47, SEQ ID NO: 48, SEQ ID NO: 49, SEQ ID NO: 50, SEQ ID NO: 51, SEQ ID NO: 52, SEQ ID NO: 53, SEQ ID NO: 93, SEQ ID NO: 95, SEQ ID NO: 96, SEQ ID NO: 97, SEQ ID NO: 98, SEQ ID NO: 99, SEQ ID NO: 100, SEQ ID NO: 101, SEQ ID NO: 102, SEQ ID NO: 103, SEQ ID NO: 104, SEQ ID NO: 105, SEQ ID NO: 106.
13 . The method of any one of claims 1 - 12 , wherein the set of antisense probes comprises one or more probes to Staphylococcus maltophilia , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 40, or SEQ ID NO: 41, SEQ ID NO: 93, or SEQ ID NO: 94.
14 . The method of any one of claims 1 - 13 , wherein the set of antisense probes comprises one or more probes to Staphylococcus agalactiae , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 37, or SEQ ID NO: 38, SEQ ID NO: 90, or SEQ ID NO: 91.
15 . The method of any one of claims 1 - 14 , wherein the set of antisense probes comprises one or more probes to Staphylococcus sp, and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 88, or SEQ ID NO: 89.
16 . The method of any one of claims 1 - 15 , wherein the set of antisense probes comprises one or more probes to Proteus mirabilis , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 27, or SEQ ID NO: 80.
17 . The method of any one of claims 1 - 16 , wherein the set of antisense probes comprises one or more probes to Enterococcus faecium , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 62, or SEQ ID NO: 63.
18 . The method of any one of claims 1 - 17 , wherein the set of antisense probes comprises one or more probes to Enterococcus faecalis , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 8 or SEQ ID NO: 61.
19 . The method of any one of claims 1 - 18 , wherein the set of antisense probes comprises one or more probes to Acinetobacter baumanniii , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 54, or SEQ ID NO: 55.
20 . The method of any one of claims 1 - 19 , wherein the set of antisense probes comprises one or more probes to Candida albicans , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 56, or SEQ ID NO: 57.
21 . The method of any one of claims 1 - 20 , wherein the set of antisense probes comprises one or more probes to Enterobacter cloacae , and wherein the one or more probes is at least 95% identical to the nucleic acid sequence set forth as SEQ ID NO: 5 or SEQ ID NO: 58.
22 . The method of any one of claims 1 - 21 , wherein the sample is a biological sample obtained from a subject.
23 . The method of any one of claims 1 - 22 , wherein the detecting hybridization between the probe indicates the presence of the species in the sample.
24 . The method of claim 23 , wherein the presence of the species in the sample indicates a subject from which the sample was obtained is infected with the organism.
25 . The method of any one of claims 1 - 24 , wherein the detectable probe is labeled.
26 . The method of claim 25 , wherein the probe is radiolabeled, fluorescently-labeled, biotin-labeled, enzymatically-labeled, or chemically-labeled.
27 . The method of claim 26 , wherein the label comprises a capture moiety.
28 . The method of claim 27 , wherein the capture moiety comprises biotin, linked to a nucleotide.
29 . The method of any one of claims 1 - 28 , wherein the probe is attached to a solid surface.
30 . The method of any one of claims 1 - 29 , further comprising contacting the sample with a second set of antisense probes, wherein the second set of probes contains at least one second detectable probe that is specific for each species to be tested, and wherein the individual probes bind to substantially the same region of the rRNA as the first set of probes, but wherein the second set of probes do not overlap in sequence identity.
31 . The method of any one of claims 1 - 30 , wherein at least one second detectable probe that is specific for each species to be tested specifically bind the nucleic acid sequences set forth as one of SEQ ID NOs: 107-159.
32 . The method of claim 30 or 31 , wherein the second detectable probe is labeled.
33 . The method of claim 32 , wherein the second detectable probe is radiolabeled, fluorescently-labeled, biotin-labeled, enzymatically-labeled, or chemically-labeled.
34 . The method of claim 32 or 33 , wherein the label comprises a capture moiety.
35 . The method of claim 34 , wherein the capture moiety comprises biotin, linked to a nucleotide.
36 . The method of any one of claim 2126 , wherein the second detectable probe is attached to a solid surface.
37 . A method for detecting a bacterial species in a sample, comprising:
contacting the sample with one or more detectable probes comprising a nucleic acid sequence capable of hybridizing to a bacterial ribosomal ribonucleic acid sequence set forth as one of SEQ ID NOs: 106-159, and detecting hybridization between the bacterial ribosomal ribonucleic acid and the probe, wherein the detection of the hybridization indicates the bacterial species is present.
38 . The method of claim 37 , wherein the one or more detectable probes comprises the nucleic acid sequence set forth as SEQ ID NO: 1-106.
39 . The method of claim 37 or 38 , wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 59, SEQ ID NO: 60, or SEQ ID NO: 64, SEQ ID NO: 65, SEQ ID NO: 66, SEQ ID NO: 67, SEQ ID NO: 68, SEQ ID NO: 69, SEQ ID NO: 70, or SEQ ID NO: 71 indicates the presence of Escherichia coli , wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 72, SEQ ID NO: 73, SEQ ID NO: 74, SEQ ID NO: 75, SEQ ID NO: 76, or SEQ ID NO: 77, or SEQ ID NO: 78 indicates the presence of Klebsiella pneumoniae , wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, or SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 79, SEQ ID NO: 81, SEQ ID NO: 82, SEQ ID NO: 83, SEQ ID NO: 84, SEQ ID NO: 85, or SEQ ID NO: 86, or SEQ ID NO: 87 indicates the presence of Pseudomonas aeruginosa , wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 40, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45, SEQ ID NO: 46, SEQ ID NO: 47, SEQ ID NO: 48, SEQ ID NO: 49, SEQ ID NO: 50, SEQ ID NO: 51, SEQ ID NO: 52, SEQ ID NO: 53, SEQ ID NO: 93, SEQ ID NO: 95, SEQ ID NO: 96, SEQ ID NO: 97, SEQ ID NO: 98, SEQ ID NO: 99, SEQ ID NO: 100, SEQ ID NO: 101, SEQ ID NO: 102, SEQ ID NO: 103, SEQ ID NO: 104, SEQ ID NO: 105, SEQ ID NO: 106 indicates the presence of Staphylococcus aureus , wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 56, or SEQ ID NO: 57 indicates the presence of Candida albicans , wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 5 or SEQ ID NO: 58 indicates the presence of Enterobacter cloacae wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 8 or SEQ ID NO: 61 indicates the presence of Enterococcus faecalis wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 62, or SEQ ID NO: 63 indicates the presence of Enterococcus faecium wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 27, or SEQ ID NO: 80 indicates the presence of Proteus mirabilis wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 37, or SEQ ID NO: 38, SEQ ID NO: 90, or SEQ ID NO: 91 indicates the presence of Staphylococcus agalactiae wherein detection of a bacterial ribosomal ribonucleic acid sequence with one or more probes at least 95% identical to SEQ ID NO: 40, or SEQ ID NO: 41, SEQ ID NO: 93, or SEQ ID NO: 94 indicates the presence of Staphylococcus maltophilia.
40 . The method of any one of claims 37 - 39 , further comprising discriminating between an a Klebsiella pneumoniae ribosomal ribonucleic acid, a Pseudomonas aeruginosa ribosomal ribonucleic acid, a Staphylococcus aureus ribosomal ribonucleic acid an Acinetobacter baumannii ribosomal ribonucleic acid, a Candida albicans ribosomal ribonucleic acid, a Enterobacter cloacae ribosomal ribonucleic acid, a Enterococcus faecalis ribosomal ribonucleic acid, a Enterococcus faecium ribosomal ribonucleic acid, a Proteus mirabilis ribosomal ribonucleic acid, or a Staphylococcus sp. ribosomal ribonucleic acid, a S. agalactiae ribosomal ribonucleic acid, or a S. maltophilia ribosomal ribonucleic acid, the method further comprising:
contacting the sample with a probe specific for the Klebsiella pneumoniae ribosomal ribonucleic acid, the Pseudomonas aeruginosa ribosomal ribonucleic acid, the Staphylococcus aureus ribosomal ribonucleic acid the Acinetobacter baumannii ribosomal ribonucleic acid, the Candida albicans ribosomal ribonucleic acid, the Enterobacter cloacae ribosomal ribonucleic acid, the Enterococcus faecalis ribosomal ribonucleic acid, the Enterococcus faecium ribosomal ribonucleic acid, the Proteus mirabilis ribosomal ribonucleic acid, the S. agalactiae ribosomal ribonucleic acid, or the S. maltophilia ribosomal ribonucleic acid; and, detecting hybridization between the probe and the Pseudomonas aeruginosa ribosomal ribonucleic acid, the Staphylococcus aureus ribosomal ribonucleic acid the Acinetobacter baumannii ribosomal ribonucleic acid, the Candida albicans ribosomal ribonucleic acid, the Enterobacter cloacae ribosomal ribonucleic acid, the Enterococcus faecalis ribosomal ribonucleic acid, the Enterococcus faecium ribosomal ribonucleic acid, the Proteus mirabilis ribosomal ribonucleic acid, the S. ag.
41 . The method of any of claims 37 - 40 , wherein the sample is a biological sample from a subject.
42 . The method of claim 41 , wherein the presence of the bacterial species in the biological sample from the subject indicates the presence of the bacterial species in the subject.
43 . The method of any one of claims 37 - 42 , wherein the detectable probe is labeled.
44 . The method of any one of claims 37 - 43 , wherein the probe is radiolabeled, fluorescently-labeled, biotin-labeled, enzymatically-labeled, or chemically-labeled.
45 . The method of claim 44 , wherein the label comprises a capture moiety.
46 . The method of claim 45 , wherein the capture moiety comprises biotin, linked to a nucleotide.
47 . The method of any one of claims 37 - 46 , wherein the probe is attached to a solid surface.
48 . A method for classifying a bacterial strain in a sample, comprising:
contacting the sample with one or more detectable antisense ribonucleic acid probes comprising a ribonucleic acid sequence capable of hybridizing to a bacterial ribosomal ribonucleic acid sequence, the one or more probes comprising the sequence set forth as SEQ ID NO: 1-106; and detecting hybridization between the bacterial ribosomal ribonucleic acid and the at one or more detectable probe, wherein the detection of the hybridization indicates the classification of the bacterial strain.
49 . The method of claim 48 , wherein the sample is a biological sample from a subject.
50 . The method of any one of claim 48 or 49 , wherein the detectable probe is labeled.
51 . The method of any one of claims 48 - 50 , wherein the probe is radiolabeled, fluorescently-labeled, biotin-labeled, enzymatically-labeled, or chemically-labeled.
52 . The method of claim 51 , wherein the label comprises a capture moiety.
53 . The method of claim 52 , wherein the capture moiety comprises biotin, linked to a nucleotide.
54 . The method of any one of claims 48 - 53 , wherein the probe is attached to a solid surface.
55 . A ribosomal ribonucleic acid (rRNA) probe for the detection of a bacterial species, comprising a nucleic acid sequence between 25 and 120 nucleotides in length capable of hybridizing to a bacterial species rRNA sequence, the probe comprising a nucleic acid sequence at least 95% identical to the nucleic acid sequence set forth as set forth as one of SEQ ID NO: 1-106, wherein the probe is labeled.
56 . The probe according claim 55 , wherein the probe is radiolabeled, fluorescently-labeled, biotin-labeled, enzymatically-labeled, or chemically-labeled.
57 . The probe according to claim 56 , wherein the label comprises a capture moiety.
58 . The probe according to claim 57 , wherein the capture moiety comprises biotin, linked to a nucleotide.
59 . A set of probes comprising at least on probe of any one of claims 55 - 58 .
60 . A kit for detecting a bacterial ribosomal ribonucleic acid in a sample, comprising:
one or more probes of any of claims 55 - 58 ; and, instructions for hybridizing the probe to a bacterial ribosomal ribonucleic acid in the sample.
61 . A device for detecting one or more microorganism is a sample, the device comprising one or more probes of any of claims 55 - 58 linked to a solid surface.
62 . A method of diagnosing a species-specific bacterial infection in a subject suspected of having a bacterial infection, comprising:
obtaining a sample comprising bacterial ribosomal ribonucleic acid from the subject; contacting the sample with one or more of the probes according to claims 55 - 58 , detecting hybridization between the bacterial ribosomal ribonucleic acid sequence present in the sample and the probe, wherein the detection of hybridization indicates that the subject is infected with a bacteria.Join the waitlist — get patent alerts
Track US2017029872A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.